Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Agriculture Tech Start-Up Accelerator to Open

A group supporting start-up companies and entrepreneurs developing new technologies in food and agriculture plans to begin next month in Minneapolis, Minnesota. . . . → Read More: Agriculture Tech Start-Up Accelerator to Open

Biotechs Partner on HPV Cancer Immunotherapies

Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV. . . . → Read More: Biotechs Partner on HPV Cancer Immunotherapies

Consortium to Speed, Expand Alzheimer’s Clinical Trials

A group of medical centers is establishing a network of clinical trial sites and processes for testing new treatments for Alzheimer’s disease. . . . → Read More: Consortium to Speed, Expand Alzheimer’s Clinical Trials

Telemedicine Kiosks Opening at Retail Pharmacies

Private kiosks providing individuals live video sessions with clinicians to diagnose non-emergency medical issues are underway in New York. . . . → Read More: Telemedicine Kiosks Opening at Retail Pharmacies

Tobacco Plants Studied as Drug Bio-Factories

A university in Australia is joining a European research project to create new types of tobacco plants for producing pharmaceuticals. . . . → Read More: Tobacco Plants Studied as Drug Bio-Factories

Engineered Cells Identify Rare Epilepsy Drug Candidates

A process using high-speed screening of drug candidates with genetically engineered cells identified potential drugs to treat a rare form of childhood epilepsy. . . . → Read More: Engineered Cells Identify Rare Epilepsy Drug Candidates

Protein Made by Synthetic Bacteria with Expanded DNA

An academic-industry lab team produced a synthetic protein from an engineered bacteria, with DNA modified to expand its number of chemical coding components. . . . → Read More: Protein Made by Synthetic Bacteria with Expanded DNA

Large-Scale Genome Editing Technology in Development

Two biotechnology companies are creating an automated process for delivering large, complex genetic cargoes into cells for genome editing. . . . → Read More: Large-Scale Genome Editing Technology in Development

Biotech, Cancer Center Partner on T-Cell Research

A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system. . . . → Read More: Biotech, Cancer Center Partner on T-Cell Research

Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies. . . . → Read More: Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal